Articles From: Biloxi Marsh Lands Corporation Announces Unaudited Results for the Second Quarter and first Six Months of 2014 and provides update to BioAmber Announces Webcast of Fiscal Second Quarter 2014 Financial Results


2014/8/8
Biloxi Marsh Lands Corporation (PINK SHEETS: BLMC) today announces its unaudited results for the second quarter of 2014 and first six months of 2014 and provides update.
Sign-up for Biloxi Marsh Lands Corporation Announces Unaudited Results for the Second Quarter and first Six Months of 2014 and provides update investment picks
Second Quarter 2014 Highlights Net income of $3.3 million attributed to Bimini Capital, or $0.27 per common share Book value per share of $0.55 MBS portfolio remains 100% invested in agency MBS Company to discuss results on Friday, August 8, 2014, at 10:00 AM ET VERO BEACH, Fla., Aug.
Sign-up for Bimini Capital Management Announces Second Quarter 2014 Results investment picks
BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins TM , today announced that it has entered into a research agreement with Roche to discover novel nanomedicines using Accurins for the treatment of diseases in therapeutic areas outside of oncology.
Sign-up for BIND Therapeutics and Roche Collaborate on Discovery of Novel Nanomedicines investment picks
BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins TM , today announced the appointments of Eric K.
Sign-up for BIND Therapeutics Appoints Two New Board Members investment picks
BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins TM , today reported financial results for the second quarter ended June 30, 2014.
Sign-up for BIND Therapeutics Reports Second Quarter 2014 Financial Results investment picks
BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins TM , announced today that Scott Minick, BIND’s President and CEO, is scheduled to present at the Wedbush 2014 Life Sciences Management Access Conference in New York on Wednesday, August 13, 2014 at 10:55 a.m. ET.
Sign-up for BIND Therapeutics to Present at Wedbush 2014 Life Sciences Management Access Conference investment picks
BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins TM , announced today that a poster presentation including Phase 2 clinical data on its lead drug candidate, BIND-014, in patients with non-small cell lung cancer (NSCLC) will be presented at the upcoming 26 th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics.
Sign-up for BIND Therapeutics to Present Data at the 26th EORTC-NCI-AACR Symposium investment picks
BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins™, today announced it will report second quarter 2014 financial results on Thursday, August 7, 2014.
Sign-up for BIND Therapeutics to Report Second Quarter 2014 Financial Results on August 7, 2014 investment picks
2014/6/24
Bing Ads builds traction within Canadian Search Community and marketers Canada NewsWire Strong results see Bing Ads becoming must-have channel for search advertisers in multiple sectors TORONTO , June 24, 2014 /CNW/ - Growing success in generating better, stronger new business leads from search advertising driven through Bing Ads is prompting marketers to increasingly utilize Bing Ads to connect with consumers.
Sign-up for Bing Ads builds traction within Canadian Search Community and marketers investment picks
Bio-Path Holdings, Inc., (NASDAQ:BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that the Company’s common stock has been added to the Russell Global, Russell 3000® and Russell Microcap® Indexes.
Sign-up for Bio-Path Holdings Added to Russell Global, Russell 3000® and Russell Microcap® Indexes investment picks
Bio-Path Holdings, Inc., (NASDAQ:BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced operational and financial results for the second quarter ended June 30, 2014.
Sign-up for Bio-Path Holdings Reports Second Quarter 2014 Operational and Financial Results investment picks
http://media.marketwire.com/attachments/201308/181926_BIO-RADLOGO.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1133451&ProfileId=051205&sourceType=1 HERCULES, CA --
Sign-up for Bio-Rad Announces the Appointment of New Board Member investment picks
http://media.marketwire.com/attachments/201308/181926_BIO-RADLOGO.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1124687&ProfileId=051205&sourceType=1 HERCULES, CA --
Sign-up for Bio-Rad Launches the First Fully-Automated 5th Generation HIV Test investment picks
http://media.marketwire.com/attachments/201308/181926_BIO-RADLOGO.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1126044&ProfileId=051205&sourceType=1 HERCULES, CA --
Sign-up for Bio-Rad Launches Vitamin D Kit for Its BioPlex 2200 System investment picks
http://media.marketwire.com/attachments/201308/181926_BIO-RADLOGO.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1135652&ProfileId=051205&sourceType=1 HERCULES, CA --
Sign-up for Bio-Rad Reports Second-Quarter 2014 Financial Results investment picks
http://media.marketwire.com/attachments/201308/181926_BIO-RADLOGO.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1129250&ProfileId=051205&sourceType=1 HERCULES, CA --
Sign-up for Bio-Rad to Report Second-Quarter 2014 Financial Results Tuesday, August 5, 2014 investment picks
MINNEAPOLIS , July 2, 2014 /PRNewswire/ -- Techne Corporation (NASDAQ: TECH) (d/b/a Bio-Techne) announced today that it has acquired Novus Biologicals for $60 million in cash.
Sign-up for Bio-Techne Announces Agreement To Acquire Novus Biologicals investment picks
MINNEAPOLIS , June 17, 2014 /PRNewswire/ -- Techne Corporation (NASDAQ: TECH) (d/b/a Bio-Techne) announced today that it has agreed to acquire ProteinSimple for $300 million in cash.
Sign-up for Bio-Techne Announces Agreement To Acquire ProteinSimple investment picks
MINNEAPOLIS , Aug.
Sign-up for Bio-Techne Announces Appointment Of Brenda Furlow As General Counsel investment picks
MINNEAPOLIS , Aug.
Sign-up for Bio-Techne Announces ProteinSimple Acquisition Completion investment picks
MINNEAPOLIS , Aug.
Sign-up for Bio-Techne Declares Dividend investment picks
MINNEAPOLIS , Aug.
Sign-up for Bio-Techne Releases Fourth Quarter And Full Year 2014 Results investment picks
LAS VEGAS , Aug.
Sign-up for BioAdaptives Announces First Product to Market investment picks
LAS VEGAS , July 17, 2014 /PRNewswire/ -- BioAdaptives, Inc. (OTCBB:BDPT) is pleased to announce Dr.
Sign-up for BioAdaptives Equine Development Success and Advisory Board Addition investment picks
2014/7/9
BioAdaptives, Inc. cleared by FINRA for quotation on OTC Bulletin Board and OTC Link under the symbol BDPT LAS VEGAS , July 9, 2014 /PRNewswire/ -- BioAdaptives, Inc. (OTC BB: BDPT) announced that it is cleared by FINRA for quotation on OTC Bulletin Board and OTC Link under the symbol BDPT effective as of July 8 , 2014.
Sign-up for BioAdaptives OTC Bulletin Board Symbol: BDPT investment picks
MINNEAPOLIS , July 23, 2014 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA) , an industrial biotechnology company producing sustainable chemicals, today announced that the underwriters of its common stock offering exercised in full their option to purchase an additional 420,000 shares of common stock at the public offering price of $12.00 per share, less underwriting discounts and commissions, in connection with its previously announced underwritten public offering of 2,800,000 shares of common stock, bringing the expected net proceeds from the offering to approximately $35.8 million , after deducting expenses of BioAmber and underwriting discounts and commissions.
Sign-up for BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering investment picks
BioAmber Announces Webcast of Fiscal Second Quarter 2014 Financial Results Canada NewsWire MINNEAPOLIS, MN , July 18, 2014 /CNW Telbec/ - BioAmber Inc. (NYSE: BIOA) , an industrial biotechnology company producing renewable chemicals, announced today that it will report its financial results for the second quarter 2014 on Thursday August 7, 2014 .
Sign-up for BioAmber Announces Webcast of Fiscal Second Quarter 2014 Financial Results investment picks
MINNEAPOLIS, MN , July 18, 2014 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA) , an industrial biotechnology company producing renewable chemicals, announced today that it will report its financial results for the second quarter 2014 on Thursday August 7, 2014 .
Sign-up for BioAmber Announces Webcast of Fiscal Second Quarter 2014 Financial Results investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Biloxi Marsh Lands Corporation Announces Unaudited Results for the Second Quarter and first Six Months of 2014 and provides update to BioAmber Announces Webcast of Fiscal Second Quarter 2014 Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices